The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.
about
MicroRNAs in the DNA Damage/Repair Network and CancerSNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancerA genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcomeSNPs in microRNA binding sites as prognostic and predictive cancer biomarkersDysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedurePolymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk.MicroRNA binding site polymorphisms as biomarkers in cancer management and research.Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish populationGenetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population.MicroRNA gene polymorphisms and environmental factors increase patient susceptibility to hepatocellular carcinoma.PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models.MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON ConsortiumAssociations between NBS1 Polymorphisms and Colorectal Cancer in Chinese PopulationSNP Regulation of microRNA Expression and Subsequent Colon Cancer RiskPolymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.Bladder cancer: a simple model becomes complex.Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.Chitooligosaccharides promote radiosensitivity in colon cancer line SW480.Genetic variants in lncRNA SRA and risk of breast cancer.Association between a functional variant in RAD51 gene's 3' untranslated region and its mRNA expression in lymphoblastoid cell lines.Genetic variants within microRNA-binding site of RAD51B are associated with risk of cervical cancer in Chinese women.The Effect of Poly(ADP-ribose) Polymerase-1 Gene 3'Untranslated Region Polymorphism in Colorectal Cancer Risk among Saudi Cohort.Single-Nucleotide Polymorphisms of Genes Involved in Repair of Oxidative DNA Damage and the Risk of Recurrent Depressive Disorder.Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics.Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer.Association between miR-199a rs74723057 and MET rs1621 polymorphisms and the risk of hepatocellular carcinoma.Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?miRNAs and long noncoding RNAs as biomarkers in human diseases.Aberrant expression of microRNAs in bladder cancer.Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx.Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo.Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.Dietary factors and microRNA-binding site polymorphisms in the IL13 gene: risk and prognosis analysis of colorectal cancer.MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.Association between MTHFR microRNA binding site polymorphisms and methotrexate concentrations in Chinese pediatric patients with acute lymphoblastic leukemia.
P2860
Q21284509-EB3CF3E1-4EAC-4D69-B8DF-22991DBDA365Q26829794-1CE52B55-EBE6-4CA9-8ED9-A9497CEF5D78Q27853343-545EF5D6-DAA9-464D-9ACD-7D1F917E65F3Q28271788-FED60A8E-447D-4ACB-B4BF-E45299EA76FCQ33640984-6C86B795-3C84-4BA3-8970-FB8BED4E0714Q33689126-58A8A9B7-5E01-4069-B088-4CA1278E39FDQ33764157-C65F3069-DDAC-493C-903E-150054FA76AAQ33864360-2C3DFDD8-C48E-4E0F-8C89-F9F805BF4CA0Q34019040-FF132A7C-9998-4E98-A8E8-4162DFD4C46AQ34640398-43F1D4C7-678D-48D3-85C7-3FA082A69A10Q35023034-CC3E9A5C-368C-4DE2-9324-76E6CEC879BEQ35108392-B42D0F23-A023-4546-9D2F-E952A4B52020Q35228413-B67613F3-C2E0-4AFB-836C-C57B7D914A8FQ35651285-DB8325A1-EF20-4AD8-BAFD-1AF2FDE393A4Q35694807-73D0DAD6-0062-484A-A71F-CA3E31837761Q35859001-BF3DEEBB-4389-4FED-9E19-863BFEDEA0F0Q35919277-C958C169-9CE6-4316-B048-32FE448D23C4Q36108115-53E4D357-9BFF-42B2-9A7A-F67258096FDFQ36589155-B3218E68-CE31-4E40-BBC2-E45513D8236CQ36698880-DB4D9F85-0596-484A-8EC4-3851ABF9586FQ36969876-5049D5B6-9012-4C2A-9ED0-5F378239932CQ37225586-57CF8A7D-2035-4F96-8FE4-B82F3CB097FAQ37297871-FFF64972-2316-474D-A885-0EA46F92E4A7Q37321041-3964210D-4C44-42C0-A2FC-A218448AADEEQ37322627-8044B21B-21A3-475C-84FB-4C750534FCA1Q37429271-1D90AE93-B5FF-450C-88B1-F402336E63B1Q37577068-B10FD934-F3AA-4051-B5E6-E219706C8AC8Q37671964-BC4FC05D-C038-4A92-8AC2-2A9CCB8D8DDFQ37694792-3F6498D7-D3B6-4E1C-A38C-F01D58785129Q37698895-14478E62-698A-4076-A98D-7B7101AF8624Q38059508-BA599341-9C70-4B5A-882B-F93A265042E8Q38088011-0EC61D14-5F58-4374-90CF-6C00905152E1Q38109811-97005413-56C1-4650-8121-D4047CE61219Q38321812-AC1759A6-0347-495A-AAD7-14134A23303CQ38740972-61106EF5-ED0D-46E6-9166-CAB2D7F3A2BAQ39107932-FA7B547B-479A-4034-8701-4F43DCBACDA9Q40147257-F3C23CC3-BF69-40C9-9CA1-82ED35492094Q40188266-63EBCD6E-C63D-4E22-969C-5D59689B5B79Q47630109-737C29DD-95A5-4215-A60C-9B15D9EA7875Q48224244-C20B9A5B-C0F2-448C-B9D1-22E38BAFC672
P2860
The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@ast
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@en
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@en-gb
type
label
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@ast
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@en
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@en-gb
prefLabel
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@ast
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@en
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@en-gb
P2093
P2860
P50
P356
P1154
2-s2.0-84857926657
P1433
P1476
The role of microRNA-binding s ...... pact on radiotherapy outcomes.
@en
P2093
Claire F Taylor
Debora Landi
Faye Elliott
Janet Hall
Laurence Vaslin
Mark T W Teo
P2860
P304
P356
10.1093/CARCIN/BGR300
P407
P5530
P577
2011-12-12T00:00:00Z
P5875
P6179
1024390296